Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma

Oral Oncology

Volumn 49, Issue 4, 2013, Pages 283-286

  Strojan, Primož ^a   Haigentz Jr , Missak ^b   Bradford, Carol R ^c   Wolf, Gregory T ^c   Hartl, Dana M ^d,e   Langendijk, Johannes A ^f   Rinaldo, Alessandra ^g   Eisbruch, Avraham ^h   Mendenhall, William M ⁱ   Forastiere, Arlene A ^j   Takes, Robert P ^k   Ferlito, Alfio ^g  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Laboratoire de Phonetique et de Phonologie   (France)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF UDINE   (Italy)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF FLORIDA   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADVANCED CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CLINICAL TRIAL (TOPIC); DISEASE SPECIFIC SURVIVAL; EDITORIAL; GASTROSTOMY; HUMAN; LARYNGECTOMY; LARYNX SQUAMOUS CELL CARCINOMA; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SATISFACTION; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; TRACHEOSTOMY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; QUALITY OF LIFE;

EID: 84875264233     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2012.11.002     Document Type: Editorial

References (32)

1. E. Babin, D. Blanchard, and M. Hitier Management of total laryngectomy patients over time: from the consultation announcing the diagnosis to long term follow-up Eur Arch Otorhinolaryngol 268 2011 1407 1419
2. The Department of Veterans Affairs Laryngeal Cancer Study Group Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 324 1991 1685 1690
3. A.A. Forastiere, H. Goepfert, M. Maor, T.F. Pajak, R. Weber, and W. Morrison Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098
4. D.G. Pfister, S.A. Laurie, G.S. Weinstein, W.M. Mendenhall, D.J. Adelstein, and K.K. Ang American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer J Clin Oncol 24 2006 3693 3704
5. J.-L. Lefebvre, and K.K. Ang Larynx Preservation Consensus Panel. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary Head Neck 31 2009 429 441
6. R.W. Hinerman, W.M. Mendenhall, R.J. Amdur, S.P. Stinger, D.B. Villaret, and K.T. Robbins Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection Head Neck 24 2002 456 467
7. J.P. Pignon, A. le Maître, E. Maillard, and MACH-NC Collaborative Group Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
8. S.S. Cheng, J.E. Terrell, C.R. Bradford, D.L. Ronis, K.E. Fowler, and M.E. Prince Variables associated with feeding tube placement in head and neck cancer Arch Otolaryngol Head Neck Surg 132 2006 655 661
9. J.E. Terrell, D.L. Ronis, K. Fowler, C.R. Bradford, D.B. Chepeha, and M.E. Prince Clinical predictors of quality of life in patients with head and neck cancer Arch Otolaryngol Head Neck Surg 130 2004 401 408
10. J.E. Terrell, S.G. Fisher, and G.T. Wolf Long-term quality of life after treatment of laryngeal cancer. The Veteran Affairs Laryngeal Cancer Study Group Arch Otolaryngol Head Neck Surg 124 1998 964 971
11. K.W. Mouw, A.A. Solanki, K.M. Stenson, M.E. Witt, E.A. Blair, and E.E. Cohen Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy Oral Oncol 48 2012 1025 1030
12. T.L. Eadie, and B.C. Bowker Coping and quality of life after total laryngectomy Otolaryngol Head Neck Surg 146 2012 959 965
13. S. Fahsl, J. Keszte, A. Boehm, H.J. Vogel, W. Völkel, and E.F. Meister Clinical relevance of quality-of-life data in laryngectomized patients Laryngoscope 122 2012 1532 1538
14. A. Mallis, P.D. Goumas, N.S. Mastronikolis, T. Panogeorgou, T. Stathas, and K. Prodromaki Factors influencing quality of life after total laryngectomy: a study of 92 patients Eur Rev Med Pharmacol Sci 15 2011 937 942
15. J.F. Ensley, J.R. Jacobs, A. Weaver, J. Kinzie, J. Crissman, and J.A. Kish Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancer of the head and neck Cancer 54 1984 811 814
16. M.B. Spaulding, S.G. Fischer, and G.T. Wolf Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma J Clin Oncol 12 1994 1592 1599
17. M. Haigentz Jr, E.E. Cohen, G.T. Wolf, P. Strojan, A. Eisbruch, and A. Ferlito The future of induction chemotherapy for head and neck squamous cell carcinoma Oral Oncol 48 2012 1065 1067
18. Cohen EEW, Karrison T, Kocherginsky M, Huang CH, Agulnik M, Mittal BB, et al. DeCIDE: a phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). J Clin Oncol 2012;30 (suppl; abstr 5500).
19. Haddad RI, Rabinowits G, Tishler RB, Adkins D, Khuri FR, Clark J, et al. The PARADIGM trial: A phase III study comparing sequential therapy (ST) to concurrent chemoradiotherapy (CRT) in locally advanced head and neck cancer (LANHC). J Clin Oncol 2012;30 (suppl; abstr 5501).
20. A. Eisbruch, A.F. Thornton, S. Urba, R.M. Esclamado, W.R. Carroll, and C.R. Bradford Chemotherapy followed by accelerated fractionated radiation for larynx preservation in patients with advanced laryngeal cancer J Clin Oncol 14 1996 2322 2330
21. J.B. Vermorken, E. Remenar, C. van Herpen, T. Gorlia, R. Mesia, and M. Degardin Cisplatin, fluorouracil and dosectaxel in unresectable head and neck cancer N Engl J Med 357 2007 1695 1704
22. M.R. Posner, D.M. Hershock, C.R. Blajman, E. Mickiewicz, E. Winquist, and V. Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
23. S. Urba, G. Wolf, A. Eisbruch, F. Worden, J. Lee, and C. Bradford Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm J Clin Oncol 24 2006 593 598
24. Y. Pointreau, P. Garaud, S. Chapet, C. Sire, C. Tuchais, and J. Tortochaux Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 2009 498 506
25. M. Al-Sarraf, M. LeBlanc, P.G. Giri, K.K. Fu, J. Cooper, and T. Vuong Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317
26. F.P. Worden, J. Moyer, J.S. Lee, J.M. Taylor, S.G. Urba, and A. Eisbruch Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion Laryngoscope 119 2009 1510 1517
27. C.M. Nutting, J.P. Morden, K.J. Harrington, T.G. Urbano, S.A. Bhide, and C. Clark Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
28. F.Y. Feng, H.M. Kim, T.H. Lyden, M.J. Haxer, F.P. Worden, and M. Feng Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results J Clin Oncol 28 2010 2732 2738
29. F.C. Holsinger, H.Y. Lin, V. Bassot, and O. Laccourreye Platin-based exclusive chemotherapy for selected patients with squamous cell carcinoma of the larynx and pharynx Cancer 115 2009 3909 3918
30. F.C. Holsinger, M.S. Kies, E.M. Diaz Jr., A.M. Gillenwater, J.S. Lewin, and L.E. Ginsberg Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer J Clin Oncol 27 2009 1976 1982
31. V. Divi, F.P. Worden, M.E. Prince, A. Eisbruch, J.S. Lee, and C.R. Bradford Chemotherapy alone for organ preservation in advanced laryngeal cancer Head Neck 32 2010 1040 1047
32. R.S. Weber, B.A. Berkey, A. Forastiere, J. Cooper, M. Maor, and H. Goepfert Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11 Arch Otolaryngol Head Neck Surg 129 2003 44 49